Privia Health director files initial Form 3

Privia Health Group, Inc. director Francis S. Soistman Jr. filed an initial Form 3, which is a required statement of beneficial ownership for insiders.

Accepted by SEC EDGAR 05/22/2026 - 08:24 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Privia Health Group, Inc. director Francis S. Soistman Jr. filed an initial Form 3, which is a required statement of beneficial ownership for insiders. The filing shows no reported transactions and no share positions or derivative holdings at this time for the reporting person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Privia Health (PRVA) Form 3 filing for Francis S. Soistman Jr. show?

The Form 3 for Privia Health director Francis S. Soistman Jr. reports his initial insider status. It shows no transactions, no common share holdings, and no derivative positions recorded as of the filing’s effective date.

Did Francis S. Soistman Jr. buy or sell any Privia Health (PRVA) shares in this Form 3?

No, the Form 3 does not report any purchases or sales of Privia Health shares. All transaction-related counts, including buy, sell, and derivative exercises, are listed as zero in the filing’s summary data.

Does the Privia Health (PRVA) Form 3 indicate any share ownership for Francis S. Soistman Jr.?

The Form 3 indicates no reported share holdings or derivative positions for Francis S. Soistman Jr. Holding entry counts and derivative summaries are empty, meaning no positions are disclosed in this particular filing.

What is the role of Francis S. Soistman Jr. at Privia Health (PRVA) according to this Form 3?

According to the Form 3, Francis S. Soistman Jr. is a director of Privia Health Group, Inc. He is not listed as an officer or ten percent owner, and no other insider roles are identified in the filing.

Are there any derivative securities reported for Francis S. Soistman Jr. in the Privia Health (PRVA) Form 3?

No derivative securities are reported for Francis S. Soistman Jr. The derivative summary section is empty, and derivative transaction counts are zero, indicating no options, warrants, or similar instruments disclosed in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SOISTMAN FRANCIS S JR

(Last) (First) (Middle)

950 N GLEBE RD

SUITE 700

(Street)

ARLINGTON VIRGINIA 22203

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/20/2026

3. Issuer Name and Ticker or Trading Symbol
Privia Health Group, Inc. [ PRVA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Power of Attorney Ex 24

No securities are beneficially owned.

	/s/ Anita Beth Adams, as attorney-in-fact	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)